vs

Side-by-side financial comparison of Inogen Inc (INGN) and Phreesia, Inc. (PHR). Click either name above to swap in a different company.

Phreesia, Inc. is the larger business by last-quarter revenue ($120.3M vs $68.6M, roughly 1.8× Inogen Inc). On growth, Phreesia, Inc. posted the faster year-over-year revenue change (12.7% vs 3.4%). Phreesia, Inc. produced more free cash flow last quarter ($12.2M vs $-1.9M).

Inogen Inc is a medical technology firm specializing in the development, production and distribution of portable oxygen concentrators and associated respiratory care products. It caters primarily to patients with chronic respiratory conditions needing long-term oxygen therapy across North America, Europe and other global markets, focusing on home care and ambulatory patient segments to enhance users' quality of life.

Phreesia, Inc. is a software as a service company that offers healthcare organizations a set of applications to automate and manage patient intake.

INGN vs PHR — Head-to-Head

Bigger by revenue
PHR
PHR
1.8× larger
PHR
$120.3M
$68.6M
INGN
Growing faster (revenue YoY)
PHR
PHR
+9.3% gap
PHR
12.7%
3.4%
INGN
More free cash flow
PHR
PHR
$14.1M more FCF
PHR
$12.2M
$-1.9M
INGN

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
INGN
INGN
PHR
PHR
Revenue
$68.6M
$120.3M
Net Profit
$4.3M
Gross Margin
51.4%
Operating Margin
-13.6%
3.1%
Net Margin
3.5%
Revenue YoY
3.4%
12.7%
Net Profit YoY
129.7%
EPS (diluted)
$-0.26
$0.07

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
INGN
INGN
PHR
PHR
Q4 25
$68.6M
$120.3M
Q3 25
$79.1M
$117.3M
Q2 25
$79.2M
$115.9M
Q1 25
$68.5M
Q4 24
$66.3M
Q3 24
$74.9M
Q2 24
$74.4M
Q1 24
$63.1M
Net Profit
INGN
INGN
PHR
PHR
Q4 25
$4.3M
Q3 25
$-5.3M
$654.0K
Q2 25
$-4.2M
$-3.9M
Q1 25
$-6.2M
Q4 24
Q3 24
$-6.0M
Q2 24
$-5.6M
Q1 24
$-14.6M
Gross Margin
INGN
INGN
PHR
PHR
Q4 25
51.4%
Q3 25
52.2%
Q2 25
52.2%
Q1 25
53.1%
Q4 24
54.7%
Q3 24
55.2%
Q2 24
57.4%
Q1 24
54.5%
Operating Margin
INGN
INGN
PHR
PHR
Q4 25
-13.6%
3.1%
Q3 25
-9.0%
-1.3%
Q2 25
-7.7%
-2.8%
Q1 25
-11.2%
Q4 24
-17.2%
Q3 24
-10.4%
Q2 24
-9.5%
Q1 24
-25.8%
Net Margin
INGN
INGN
PHR
PHR
Q4 25
3.5%
Q3 25
-6.7%
0.6%
Q2 25
-5.2%
-3.4%
Q1 25
-9.0%
Q4 24
Q3 24
-8.0%
Q2 24
-7.5%
Q1 24
-23.1%
EPS (diluted)
INGN
INGN
PHR
PHR
Q4 25
$-0.26
$0.07
Q3 25
$-0.20
$0.01
Q2 25
$-0.15
$-0.07
Q1 25
$-0.25
Q4 24
$-0.41
Q3 24
$-0.25
Q2 24
$-0.24
Q1 24
$-0.62

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
INGN
INGN
PHR
PHR
Cash + ST InvestmentsLiquidity on hand
$103.7M
$106.4M
Total DebtLower is stronger
$3.4M
Stockholders' EquityBook value
$192.2M
$320.3M
Total Assets
$298.6M
$423.5M
Debt / EquityLower = less leverage
0.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
INGN
INGN
PHR
PHR
Q4 25
$103.7M
$106.4M
Q3 25
$106.5M
$98.3M
Q2 25
$103.7M
$90.9M
Q1 25
$118.9M
Q4 24
$113.8M
Q3 24
$105.7M
Q2 24
$97.9M
Q1 24
$107.4M
Total Debt
INGN
INGN
PHR
PHR
Q4 25
$3.4M
Q3 25
$4.6M
Q2 25
$6.2M
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
INGN
INGN
PHR
PHR
Q4 25
$192.2M
$320.3M
Q3 25
$197.2M
$298.0M
Q2 25
$199.5M
$282.2M
Q1 25
$198.0M
Q4 24
$173.9M
Q3 24
$185.4M
Q2 24
$187.6M
Q1 24
$191.9M
Total Assets
INGN
INGN
PHR
PHR
Q4 25
$298.6M
$423.5M
Q3 25
$307.0M
$408.6M
Q2 25
$312.0M
$400.4M
Q1 25
$308.4M
Q4 24
$296.2M
Q3 24
$306.2M
Q2 24
$308.9M
Q1 24
$315.6M
Debt / Equity
INGN
INGN
PHR
PHR
Q4 25
0.01×
Q3 25
0.02×
Q2 25
0.02×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
INGN
INGN
PHR
PHR
Operating Cash FlowLast quarter
$-943.0K
$15.5M
Free Cash FlowOCF − Capex
$-1.9M
$12.2M
FCF MarginFCF / Revenue
-2.8%
10.1%
Capex IntensityCapex / Revenue
1.4%
2.7%
Cash ConversionOCF / Net Profit
3.62×
TTM Free Cash FlowTrailing 4 quarters
$-13.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
INGN
INGN
PHR
PHR
Q4 25
$-943.0K
$15.5M
Q3 25
$2.2M
$14.8M
Q2 25
$4.3M
$14.8M
Q1 25
$-16.8M
Q4 24
$-3.0M
Q3 24
$7.0M
Q2 24
$6.7M
Q1 24
$-4.7M
Free Cash Flow
INGN
INGN
PHR
PHR
Q4 25
$-1.9M
$12.2M
Q3 25
$1.6M
$13.1M
Q2 25
$3.7M
$11.3M
Q1 25
$-17.1M
Q4 24
$-3.3M
Q3 24
$5.3M
Q2 24
$6.6M
Q1 24
$-6.1M
FCF Margin
INGN
INGN
PHR
PHR
Q4 25
-2.8%
10.1%
Q3 25
2.0%
11.1%
Q2 25
4.6%
9.8%
Q1 25
-24.9%
Q4 24
-5.0%
Q3 24
7.1%
Q2 24
8.9%
Q1 24
-9.6%
Capex Intensity
INGN
INGN
PHR
PHR
Q4 25
1.4%
2.7%
Q3 25
0.7%
1.5%
Q2 25
0.9%
3.0%
Q1 25
0.4%
Q4 24
0.5%
Q3 24
2.2%
Q2 24
0.1%
Q1 24
2.1%
Cash Conversion
INGN
INGN
PHR
PHR
Q4 25
3.62×
Q3 25
22.68×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

INGN
INGN

Other$36.1M53%
Non Us$32.5M47%

PHR
PHR

Subscription And Services$55.5M46%
Network Solutions$37.4M31%
Payment Processing Fees$27.4M23%

Related Comparisons